Roles
Assistant Professor
-
Biography
Dr. Takashi Satoh is a board-certified dermatologist and physician-scientist specializing in inflammatory and autoinflammatory skin diseases. He earned his M.D. and Ph.D. from Chiba University School of Medicine in Japan and completed postdoctoral research at the University of Zurich in Switzerland, where he studied inflammasome biology and neutrophilic dermatoses. Before joining the University of Miami Miller School of Medicine in 2025, he served as Principal Investigator in the Department of Dermatology and Allergy at the University Hospital of Munich (LMU) in Germany.
Dr. Satoh’s research focuses on elucidating the molecular mechanisms underlying inflammatory and autoinflammatory skin diseases such as hidradenitis suppurativa, pyoderma gangrenosum, Sweet syndrome, and cryopyrin-associated periodic syndromes (CAPS), with particular emphasis on IL-1 and IL-36 cytokine pathways and inflammasome activation. He also investigates the pathogenesis of cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), EGFR/MEK inhibitor-induced acneiform eruptions, and acute generalized exanthematous pustulosis (AGEP). His work has been published in leading journals such as The Journal of Clinical Investigation, The British Journal of Dermatology, and Nature, and he has contributed chapters to Fitzpatrick’s Dermatology and Braun-Falco’s Dermatology. -
Education & Training
Education
-
Research Interests
Clinical and Research Interests:
Inflammatory and autoinflammatory skin diseases
Neutrophilic dermatoses (hidradenitis suppurativa, pyoderma gangrenosum, Sweet syndrome)
Severe drug reactions (SJS/TEN, pustular drug eruptions)
Inflammasome and cytokine signaling (IL-1, IL-36)
Cell death pathways in inflammatory and drug-induced skin diseases
Molecular mechanisms of neutrophil extracellular trap (NET) formation and NETosis
Translational and multi-omics dermatology